{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:23:40Z","timestamp":1775975020320,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Janssen Pharmaceuticals NV"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12325-025-03196-6","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:30:04Z","timestamp":1745915404000},"page":"2922-2936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Impacts of Caregiving for Patients with X-Linked Retinitis Pigmentosa (XLRP): Findings from the EXPLORE XLRP-2 Study"],"prefix":"10.1007","volume":"42","author":[{"given":"Michel","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Parmeggiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Bremond-Gignac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avril","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabin","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique Rodr\u00edguez","family":"de la R\u00faa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ygal","family":"Rotenstreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eeva-Marja","family":"Sankila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Van Denderen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Denee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4679-2050","authenticated-orcid":false,"given":"Katalin","family":"Pungor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"13","key":"3196_CR1","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.3390\/ijerph19138208","volume":"19","author":"C Valcarcel-Nazco","year":"2022","unstructured":"Valcarcel-Nazco C, Ramallo-Farina Y, Linertova R, Ramos-Goni JM, Garcia-Perez L, Serrano-Aguilar P. Health-related quality of life and perceived burden of informal caregivers of patients with rare diseases in selected European countries. Int J Environ Res Public Health. 2022;19(13):8208.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"3196_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/eye.2015.235","volume":"30","author":"M Vukicevic","year":"2016","unstructured":"Vukicevic M, Heraghty J, Cummins R, Gopinath B, Mitchell P. Caregiver perceptions about the impact of caring for patients with wet age-related macular degeneration. Eye (Lond). 2016;30(3):413\u201321.","journal-title":"Eye (Lond)"},{"key":"3196_CR3","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2147\/OPTH.S365486","volume":"16","author":"N Cross","year":"2022","unstructured":"Cross N, van Steen C, Zegaoui Y, Satherley A, Angelillo L. Retinitis pigmentosa: burden of disease and current unmet needs. Clin Ophthalmol. 2022;16:1993\u20132010.","journal-title":"Clin Ophthalmol"},{"key":"3196_CR4","doi-asserted-by":"publisher","first-page":"4683427","DOI":"10.1155\/2016\/4683427","volume":"2016","author":"Z Khan","year":"2016","unstructured":"Khan Z, Braich PS, Rahim K, et al. Burden and depression among caregivers of visually impaired patients in a Canadian population. Adv Med. 2016;2016:4683427.","journal-title":"Adv Med"},{"issue":"6","key":"3196_CR5","doi-asserted-by":"publisher","first-page":"igaa043","DOI":"10.1093\/geroni\/igaa043","volume":"4","author":"V Varadaraj","year":"2020","unstructured":"Varadaraj V, Chung SE, Swiatek KS, et al. Caring for older adults with vision impairment and dementia. Innov Aging. 2020;4(6):igaa043.","journal-title":"Innov Aging"},{"issue":"5","key":"3196_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcjo.2022.04.003","volume":"58","author":"DR Pur","year":"2023","unstructured":"Pur DR, Bassi A, Malvankar-Mehta MS. Impact on caregivers of patients with eye diseases: systematic review and meta-analysis. Can J Ophthalmol. 2023;58(5):433\u201342.","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"3196_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2022.101284","volume":"15","author":"RE Ruiz-Lozano","year":"2022","unstructured":"Ruiz-Lozano RE, de la Rosa-Pacheco S, Hernandez-Camarena JC, et al. Burden and depression among informal caregivers of visually impaired patients in Mexico. Disabil Health J. 2022;15(3): 101284.","journal-title":"Disabil Health J"},{"issue":"4","key":"3196_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/138920211795860107","volume":"12","author":"S Ferrari","year":"2011","unstructured":"Ferrari S, Di Iorio E, Barbaro V, Ponzin D, Sorrentino FS, Parmeggiani F. Retinitis pigmentosa: genes and disease mechanisms. Curr Genom. 2011;12(4):238\u201349.","journal-title":"Curr Genom"},{"issue":"3","key":"3196_CR9","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1167\/iovs.06-0971","volume":"48","author":"MA Sandberg","year":"2007","unstructured":"Sandberg MA, Rosner B, Weigel-DiFranco C, Dryja TP, Berson EL. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Invest Ophthalmol Vis Sci. 2007;48(3):1298\u2013304.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"14","key":"3196_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1167\/iovs.61.14.36","volume":"61","author":"V Di Iorio","year":"2020","unstructured":"Di Iorio V, Karali M, Melillo P, et al. Spectrum of disease severity in patients with X-linked retinitis pigmentosa due to RPGR mutations. Invest Ophthalmol Vis Sci. 2020;61(14):36\u201336.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3196_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100898","volume":"82","author":"SR De Silva","year":"2021","unstructured":"De Silva SR, Arno G, Robson AG, et al. The X-linked retinopathies: physiological insights, pathogenic mechanisms, phenotypic features and novel therapies. Prog Retin Eye Res. 2021;82: 100898.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"3196_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/aos.14662","volume":"99","author":"M Zada","year":"2021","unstructured":"Zada M, Cornish EE, Fraser CL, Jamieson RV, Grigg JR. Natural history and clinical biomarkers of progression in X-linked retinitis pigmentosa: a systematic review. Acta Ophthalmol. 2021;99(5):499\u2013510.","journal-title":"Acta Ophthalmol"},{"key":"3196_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2147\/CEOR.S297287","volume":"13","author":"M Chivers","year":"2021","unstructured":"Chivers M, Li N, Pan F, Wieffer H, Slowik R, Leartsakulpanitch J. The burden of X-linked retinitis pigmentosa on patients and society: a narrative literature review. Clinicoecon Outcomes Res. 2021;13:565\u201372.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"9","key":"3196_CR14","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.ophtha.2015.05.039","volume":"122","author":"J Comander","year":"2015","unstructured":"Comander J, Weigel-DiFranco C, Sandberg MA, Berson EL. Visual function in carriers of X-linked retinitis pigmentosa. Ophthalmology. 2015;122(9):1899\u2013906.","journal-title":"Ophthalmology"},{"issue":"5","key":"3196_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.oret.2019.11.010","volume":"4","author":"AT Fahim","year":"2020","unstructured":"Fahim AT, Sullivan LS, Bowne SJ, et al. X-chromosome inactivation is a biomarker of clinical severity in female carriers of RPGR-associated X-linked retinitis pigmentosa. Ophthalmol Retina. 2020;4(5):510\u201320.","journal-title":"Ophthalmol Retina"},{"key":"3196_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2023.101190","volume":"96","author":"SA Gocuk","year":"2023","unstructured":"Gocuk SA, Jolly JK, Edwards TL, Ayton LN. Female carriers of X-linked inherited retinal diseases\u2013genetics, diagnosis, and potential therapies. Prog Retin Eye Res. 2023;96: 101190.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"3196_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.oret.2020.01.005","volume":"4","author":"F Parmeggiani","year":"2020","unstructured":"Parmeggiani F. X-chromosome insight for targeting gene therapy. Ophthalmol Retina. 2020;4(5):521\u20132.","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"3196_CR18","first-page":"1","volume":"44","author":"BL Lam","year":"2024","unstructured":"Lam BL, Scholl HPN, Doub D, Sperling M, Hashim M, Li N. A systematic literature review of disease progression reported in Rpgr -associated X-linked retinitis pigmentosa. Retina. 2024;44(1):1\u20139.","journal-title":"Retina"},{"issue":"7","key":"3196_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/healthcare11070988","volume":"11","author":"K Watanabe","year":"2023","unstructured":"Watanabe K, Hiratsuka Y, Yamamoto S, Murakami A. Economic impacts and quality of life for caregivers of patients with retinitis pigmentosa: a cross-sectional Japanese study. Healthcare (Basel). 2023;11(7):988.","journal-title":"Healthcare (Basel)"},{"key":"3196_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03546-8","author":"F Parmeggiani","year":"2025","unstructured":"Parmeggiani F, Weber M, Bremond-Gignac D, et al. The burden of X-linked retinitis pigmentosa (XLRP) on patient experience and patient-reported outcomes (PROs): findings from the EXPLORE XLRP-2 study. Eye (Lond). 2025. https:\/\/doi.org\/10.1038\/s41433-024-03546-8.","journal-title":"Eye (Lond)"},{"key":"3196_CR21","doi-asserted-by":"crossref","unstructured":"Guy W. CGI clinical global impressions. EC-DEU Assessment Manual for Psychopharmacology 1976.","DOI":"10.1037\/t48216-000"},{"key":"3196_CR22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727\u201336.","journal-title":"Qual Life Res"},{"issue":"4","key":"3196_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/hsw\/hlt019","volume":"38","author":"SS Tebb","year":"2013","unstructured":"Tebb SS, Berg-Weger M, Rubio DM. The caregiver well-being scale: developing a short-form rapid assessment instrument. Health Soc Work. 2013;38(4):222\u201330.","journal-title":"Health Soc Work"},{"key":"3196_CR24","doi-asserted-by":"crossref","unstructured":"Bagheri S, Zarshenas L, Rakhshan M, Sharif F, Sarani EM, Shirazi ZH. Translation, cultural adaptation and validation of the caregiver well-being scale (CWBS) in Iranian schizophrenia caregivers: a methodological and cross-sectional study. 2020.","DOI":"10.21203\/rs.3.rs-113686\/v1"},{"key":"3196_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7525-1-29","volume":"1","author":"RP Snaith","year":"2003","unstructured":"Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"3196_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/occmed\/kqu024","volume":"64","author":"AF Stern","year":"2014","unstructured":"Stern AF. The hospital anxiety and depression scale. Occup Med (Lond). 2014;64(5):393\u20134.","journal-title":"Occup Med (Lond)"},{"key":"3196_CR27","unstructured":"Colebrander A, International Council of Ophthalmology. Visual standards: aspects and ranges of vision loss with emphasis on population surveys: report prepared for the international council of ophthalmology at the 29th international congress of ophthalmology, Sydney, Australia, April 2002."},{"issue":"6","key":"3196_CR28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10198-019-01054-1","volume":"20","author":"T Grochtdreis","year":"2019","unstructured":"Grochtdreis T, Dams J, Konig HH, Konnopka A. Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set. Eur J Health Econ. 2019;20(6):933\u201344.","journal-title":"Eur J Health Econ"},{"issue":"9","key":"3196_CR29","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s10198-022-01559-2","volume":"24","author":"L Gautier","year":"2023","unstructured":"Gautier L, Azzi J, Saba G, Bonnelye G, de Pouvourville G. Population norms in France with EQ-5D-5L: health states, value indexes, and VAS. Eur J Health Econ. 2023;24(9):1517\u201330.","journal-title":"Eur J Health Econ"},{"issue":"2","key":"3196_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11136-021-02971-6","volume":"31","author":"L Van Wilder","year":"2022","unstructured":"Van Wilder L, Charafeddine R, Beutels P, et al. Belgian population norms for the EQ-5D-5L, 2018. Qual Life Res. 2022;31(2):527\u201337.","journal-title":"Qual Life Res"},{"issue":"8","key":"3196_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/OPX.0000000000000005","volume":"90","author":"AG Malkin","year":"2013","unstructured":"Malkin AG, Goldstein JE, Perlmutter MS, Massof RW, Low Vision Research Network Study Group. Responsiveness of the EQ-5D to the effects of low vision rehabilitation. Optom Vis Sci. 2013;90(8):799\u2013805.","journal-title":"Optom Vis Sci"},{"issue":"1","key":"3196_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13023-023-02697-3","volume":"18","author":"M Maltseva","year":"2023","unstructured":"Maltseva M, Schubert-Bast S, Zollner JP, et al. Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in Germany. Orphanet J Rare Dis. 2023;18(1):98.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3196_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13023-022-02601-5","volume":"18","author":"S Acaster","year":"2023","unstructured":"Acaster S, Lo SH, Nestler-Parr S. A survey exploring caregiver burden and health-related quality of life in hereditary transthyretin amyloidosis. Orphanet J Rare Dis. 2023;18(1):17.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"3196_CR34","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/s41433-021-01821-6","volume":"36","author":"J Enoch","year":"2022","unstructured":"Enoch J, Dickinson C, Subramanian A. What support do caregivers of people with visual impairment receive and require? An exploratory study of UK healthcare and charity professionals\u2019 perspectives. Eye (Lond). 2022;36(11):2179\u201387.","journal-title":"Eye (Lond)"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03196-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T08:00:16Z","timestamp":1747468816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03196-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3196"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03196-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michel Weber, Andrew Lotery, Markus Ritter and Enrique Rodr\u00edguez de la R\u00faa have received consulting fees from Janssen and Novartis. Francesco Parmeggiani has received consulting fees from AbbVie, Bayer, Janssen, Novartis and Roche. Dominique Bremond-Gignac has received consulting fees from Alcon, Janssen, Novartis, Santen and Thea. Avril Daly, Nabin Paudel and Eeva-Marja Sankila have no competing interests. Ygal Rotenstreich has received a consulting fee from Janssen. Katarina Stingl has received consulting fees to the University from Janssen, Novartis, ProQR Therapeutics, Santen, and ViGeneron. Marjolein Lahaye, Jacqueline Van Denderen, Tom Denee, and Katalin Pungor are employees of Johnson and Johnson.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study received local ethical committee approval at each study site (Austria, Ethik Komission Medizinische Universit\u00e4t Wien: 1088\/2022; Belgium, Ethics Committee Research UZ\/UK Leuven: B3222022000832; UK, Health Research Authority Integrated Research Application System: 307690; Finland, HUSin Alueellinen L\u00e4\u00e4ketieteellinen Tutkimuseettinen Toimikunta: 48\/2022; France, Comit\u00e9 de Protection des Personnes Nord Ouest IV: 22.02349.000114; Germany, EC Medical Faculty of Eberhard-Karls-University and University Clinic T\u00fcbingen: 839\/2021BO1, 2022-200343-BO-bet; Israel, EC of the Chaim Cheba Medical Centre: 9186-22-SMC; Israel, EC of the Soroka Medical Center: 0391-21-SOR; Italy, Comitato Ethico di Area Vasta Emilia Centro: 1026\/2021\/Oss\/AOUFe; The Netherlands, Dutch Clinical Research Foundation: 21.177\/VS; Spain, Comit\u00e9 de \u00c9tica de la Investigaci\u00f3n con medicamentos Euskadi: PI2022051) (see Supplementary Table S2 for more details) and adhered to the tenets of the Declaration of Helsinki. All participants gave informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}